Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.
Amit Vasanji, PhD, and Brett A. Hoover
Advertisement
Articles by Amit Vasanji, PhD, and Brett A. Hoover
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
2
Beyond Patient Centricity: What Rare Disease Research Gets Right
3
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
4
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
5